Chapter

Introduction

From Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection | Scientific Reports by Sambif

Concepts

1. Clinical Manifestations

   "Since the emergence of coronavirus disease 2019 (COVID-19), increasing attention has been directed towards the heterogeneous clinical manifestations associated with SARS-CoV-2 infection. Patients wit

2. PCC Definition

   "According to the World Health Organization (WHO), PCC is defined as the presence of symptoms lasting for at least three months after the onset of confirmed or probable SARS-CoV-2 infection, which can

3. Evidence Gaps

   "Previous research has described the broad clinical spectrum and prevalence of PCC,6,7 but evidence regarding its long-term trajectory and data of factors associated with persistent disease is limited

4. Cohort Study

   "To address these gaps, we conducted a longitudinal cohort study combining retrospective assessment of acute-phase symptoms with prospective follow-up for up to four years. In this exploratory study,